Hepion Pharmaceuticals

Hepion Pharmaceuticals logo
🇺🇸United States
Ownership
Public
Employees
22
Market Cap
$4.5M
Website
http://www.hepionpharma.com
Introduction

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2...

© Copyright 2024. All Rights Reserved by MedPath